Drug intelligence / Profile preview

Bronchipret

Development stage
Phase 2
Lead developer
Bionorica
Modality
Small Molecules
Administration
Oral
01

Overview

Bronchipret is a phytotherapeutic (herbal) medicinal product developed by Bionorica SE for the treatment of acute bronchitis and cough associated with excessive mucus production. The formulation typically combines thyme herb extract with either ivy leaf extract (found in the syrup and drops) or primrose root extract (found in the tablet form). Its therapeutic efficacy is attributed to a multi-target mechanism: it acts as a secretolytic by reducing mucus viscosity, a bronchospasmolytic by relaxing bronchial smooth muscle, and exhibits anti-inflammatory and antimicrobial properties. Specifically, alpha-hederin from ivy extract has been shown to inhibit the internalization of beta-2 adrenergic receptors, thereby enhancing bronchodilation. Thyme extracts contribute through their essential oils, such as thymol and carvacrol, which provide secretomotor and antibacterial activity. Clinical studies have demonstrated that Bronchipret significantly reduces cough frequency and improves overall symptom scores in patients with respiratory tract infections.

Brand names
Bronchipret
Other names
thyme herb + ivy leaf fluid extract
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PDE4B (3',5'-cyclic-AMP phosphodiesterase 4B)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Bronchipret.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchipret.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call